HER2 Support Group Forums - View Single Post - HER2-targeted antibody drug conjugate shows encouraging responses, long-lasting clini

News · 06-05-2023, 07:00 PM

In a new study of trastuzumab deruxtecan, a HER2-targeted antibody drug conjugate, researchers observed encouraging responses and long-lasting clinical benefit in several tumor types.

More...

06-05-2023, 07:00 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,123	HER2-targeted antibody drug conjugate shows encouraging responses, long-lasting clini In a new study of trastuzumab deruxtecan, a HER2-targeted antibody drug conjugate, researchers observed encouraging responses and long-lasting clinical benefit in several tumor types. More...